Life Sciences Nova Scotia
  • About
    • COL
      • Who we are
      • What we do
    • COL
      • Why work in Nova Scotia?
    • COL
      • Contact us
  • Members
    • COL
      • Member directory
    • COL
      • Member benefits
    • COL
      • Become a member
  • Resources
    • COL
      • Member Programs
    • COL
      • News & success stories
    • COL
      • Member Job Board
  • Events
  • Podcast
Select Page

Research and innovation leading to better outcomes for Canadians living with diabetes

by administrator | May 16, 2018 | News, Novo Nordisk

See original story here In August 1922, 13-year-old Elizabeth Evans Hughes, extremely weak at only 45 pounds, was one of the first patients treated with insulin. It saved her life. She went on to graduate from college, get married and have three children. She died...

Xultophy® approved in Canada for the treatment of adults with type 2 diabetes

by administrator | Apr 18, 2018 | News, Novo Nordisk

See original story here Once-daily Xultophy® has been shown to help patients achieve blood glucose targets Novo Nordisk announced today that Health Canada has approved Xultophy®as an adjunct to lifestyle modifications, for the once-daily treatment of adults with type...

Recent Posts

  • 3D BioFibR Appoints Dr. Michael Francis as Independent Board Member
  • Life Sciences Nova Scotia Announces the appointment of 5 New Board Members
  • BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing
  • Federal Government Prescribes $2.9M Boost For Life Sciences Sector
  • Entrevestor Live – An Awesome Display of Atlantic Canadian Innovation
No comments to show.

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow